Osteoblastic Differentiation of Human and Equine Adult Bone Marrow-Derived Mesenchymal Stem Cells when BMP-2 or BMP-7 Homodimer Genetic Modification Is Compared to BMP-2/7 Heterodimer Genetic Modification in the Presence and Absence of Dexamethasone

被引:43
作者
Carpenter, Ryan S. [1 ]
Goodrich, Laurie R. [1 ]
Frisbie, David D. [1 ]
Kisiday, John D. [1 ]
Carbone, Beth [1 ]
McIlwraith, C. Wayne [1 ]
Centeno, Christopher J. [3 ]
Hidaka, Chisa [2 ]
机构
[1] Colorado State Univ, Orthopaed Res Ctr, Ft Collins, CO 80523 USA
[2] Hosp Special Surg, Tissue Engn Repair & Regenerat Program, New York, NY 10021 USA
[3] Centeno Schultz Clin, Broomfield, CO 80621 USA
关键词
bone marrow derived mesenchymal stem cells; genetic modification; BMP-2; BMP-7; heterodimer; MORPHOGENETIC PROTEIN-2; STROMAL CELLS; IN-VITRO; OSTEOGENIC DIFFERENTIATION; SEGMENTAL DEFECTS; MODEL; RHBMP-2; CHONDROGENESIS; THERAPY; RATS;
D O I
10.1002/jor.21126
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Bone marrow-derived mesenchymal stem cells (BMDMSCs) have been targeted for use in enhancement of bone healing, and their osteogenic potential may be further augmented by genes encoding bone morphogenetic proteins (BMP's) The purpose of this study was to compare the effect of genetic modification of human and equine BMDMSCs with BMP-2 or -7 or BMP-2 and -7 on their osteoblastogemc differentiation in the presence or absence of dexamethasone The BMDMSCs were harvested from the iliac crest of three human donors and tuber coxae of' three equine donors Monolayer cells were genetically modified using adenovirus vectors encoding BMP-2, -7 or both and cultured in the presence or absence of dexamethasone Expression of BMPs was confirmed by enzyme linked immunosorbent assay (ELISA) To evaluate osteoblastic differentiation, cellular morphology was assessed every other day and expression and secretion of alkaline phosphatase (ALP), as well as expression levels of osteonectin (OSTN), osteocalcin (OCN), and runt-related transcription factor-2 (Runx2) were measured for up to 14 days Human and equine BMDMSCs showed a capacity for osteogenic differentiation regardless of genetic modification or dexamethasone supplementation Dexamethasone supplementation was more important for osteoblastogemc differentiation of equine BMDMSCs than human BMDMSCs Genetic modification of BMDMSCs increased ALP secretion with AdBMP-2 homodimer having the greatest effect in both human and equine cells compared to AdBMP 7 or AdBMP 2/7 BMP protein elution rates reached their maximal concentration between day 4 and 8 and remained relatively stable thereafter, suggesting that genetically modified BMDMSCs could be useful for cell-based delivery of BM Ps to a site of bone formation (C 2010 Orthopaedic Research Society Published by Wiley Periodicals, Inc J Orthop Res 28 1330-13:37, 2010
引用
收藏
页码:1330 / 1337
页数:8
相关论文
共 47 条
[1]   POTENT ECTOPIC BONE-INDUCING ACTIVITY OF BONE MORPHOGENETIC PROTEIN-4/7 HETERODIMER [J].
AONO, A ;
HAZAMA, M ;
NOTOYA, K ;
TAKETOMI, S ;
YAMASAKI, H ;
TSUKUDA, R ;
SASAKI, S ;
FUJISAWA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 210 (03) :670-677
[2]   Immunogenicity of adult mesenchymal stem cells: Lessons from the fetal allograft [J].
Barry, FP ;
Murphy, JM ;
English, K ;
Mahon, BP .
STEM CELLS AND DEVELOPMENT, 2005, 14 (03) :252-265
[3]   Biomechanical and histological aspects of fracture healing, stimulated with osteogenic protein-1 [J].
Blokhuis, TJ ;
den Boer, FC ;
Bramer, JAM ;
Jenner, JMGT ;
Bakker, FC ;
Patka, P ;
Haarman, HJTM .
BIOMATERIALS, 2001, 22 (07) :725-730
[4]   Early osteoblastic differentiation induced by dexamethasone enhances adenoviral gene delivery to marrow stromal cells [J].
Blum, JS ;
Parrott, MB ;
Mikos, AG ;
Barry, MA .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2004, 22 (02) :411-416
[5]   BMP-6 accelerates both chondrogenesis and mineral maturation in differentiating chick limb-bud mesenchymal cell cultures [J].
Boskey, AL ;
Paschalis, EP ;
Binderman, I ;
Doty, SB .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 84 (03) :509-519
[6]   Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model [J].
Bostrom, M ;
Lane, JM ;
Tomin, E ;
Browne, M ;
Berberian, W ;
Turek, T ;
Smith, J ;
Wozney, J ;
Schildhauer, T .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1996, (327) :272-282
[7]  
Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343
[8]   Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs) [J].
Cheng, HW ;
Jiang, W ;
Phillips, FM ;
Haydon, RC ;
Peng, Y ;
Zhou, L ;
Luu, HH ;
An, NL ;
Breyer, B ;
Vanichakarn, P ;
Szatkowski, JP ;
Park, JY ;
He, TC .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A (08) :1544-1552
[9]   EFFECT OF RECOMBINANT HUMAN OSTEOGENIC PROTEIN-1 ON HEALING OF SEGMENTAL DEFECTS IN NONHUMAN-PRIMATES [J].
COOK, SD ;
WOLFE, MW ;
SALKELD, SL ;
RUEGER, DC .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1995, 77A (05) :734-750
[10]  
COOK SD, 1994, CLIN ORTHOP RELAT R, P302